The Committee on Energy and Commerce is the oldest standing legislative committee (established 1795) in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee. The Energy and Commerce Committee is at the forefront of all issues and policies powering America’s economy, including our global competitive edge in energy, technology, and health care. The committee is led by E&C Chairman Brett Guthrie (KY-02) and E&C Ranking Member Frank Pallone (NJ-06). The Subcommittee on Health is led by Chairman Morgan Griffith (VA-09) and Ranking Member Diana DeGette (C)-01).
Today's hearing gives us the opportunity to continue the Energy and
Commerce Committee's leadership on artificial intelligence or AI
by examining current applications of AI across the healthcare sector.
Last Congress, the subcommittee held a similar hearing on AI and
machine learning. It is critical that we continue these types of
educational hearings to understand the evolving health AI landscape
and ensure that Congress keeps up with the many advances in this
space, applications of AI and machine learning have increased across
the healthcare sector in recent years and will only play a more pronounced
role in the daily lives of all Americans moving forward. In the healthcare
space today, AI is being deployed by innovators to empower patients
along their personal healthcare journey. Support healthcare providers
and reduce unnecessary administrative burdens. I look forward to
learning more about these real world applications from our panel
of experts today. I also believe this AI applications advance. It
is critical that Congress continues to examine this landscape to
ensure proper safety and proper oversight. These AI applications
could be hugely beneficial to patients and providers, but they are
to assist
they are to assist and not to replace the clinical workforce today.
I want to briefly highlight a few examples of how AI is being used
to improve patient experiences and outcomes in the market today.
Pharmaceutical companies are using AI to help improve core scientific
research functions and develop life saving treatments and cures,
as well as using AI to expedite clinical trials to bring safe and
effective medicines to market quicker. Insurance companies are using
AI to process claims in order to get care to patients quicker. But
this is an area where oversight is needed to make sure that the AI
is not being used in an inappropriate way. Uh, and we've seen that
on occasion. So we've got to be careful. Physicians in hospitals
who've been dealing with documentation burdens or using AI to assist
in writing up and consolidating post visits records, which has helped
reduce documentation time by roughly 1/3 in some cases and allowed
for doctors to spend more time. That's right, you get to spend more
time with their patients. What a novel idea. Companies who develop
medical devices are using machine learning to better understand certain
diseases and help advance innovations to deliver more clinically
appropriate and effective care interventions.
The Trump administration has also been forward leaning on advancing
AI in the health space and streamlining a regulations to increase
its application. I applaud the work of the current administration
to incorporate AI in a responsible manner that can help improve care.
To date, the CMS Innovation Center is working to utilize AI and machine
learning to identify waste, fraud, and abuse in federal healthcare
systems and to root out improper taxpayer spending. The FDA has incorporated
the use of AI to drastically shorten the time needed to complete
some tasks in their review process. Researchers at NIH have developed
an AI algorithm that modernizes the process of matching potential
clinical trial volunteers to suitable trials, cutting down administrative
time by 40% while maintaining the same level of placement accuracy,
and one would hope that would even get to be a better placement accuracy.
These are only a few examples of the many ways the administration
is integrating AI and streamlining the way our American healthcare
system operates with all these innovative advancements being leveraged
across the American healthcare ecosystem, it is paramount that we
ensure proper oversight is being applied. because the application
of AI and machine learning is only going to increase. We must ensure
that these tools continue to empower and not replace the providers
that serve our communities across the nation. These tools should
help improve the patient experience and ultimately access to care,
particularly in rural areas like the one that I represent in Virginia's
9th congressional district. I hope we have a constructive conversation
today about the opportunities and the risks that come with AI and
how our committee should be thinking about the role we can play in
helping shape the future of AI and healthcare. I'm looking forward
to hearing more from our witnesses and the members on this subcommittee
on the application of AI